FY2015 CSR Website

CSR > Site Reports > Zeon Group (Japan) > Zeon Medical Inc.

Zeon Medical Inc.

Introduction to Zeon Medical Inc.
Zeon Medical Inc. was established in 1989 as a wholly owned subsidiary of ZeonCorporation. It inherited the medical business of its parent company, which from the 1970s
had conducted research into artificial kidneys, followed by auxiliary artificial heart pumps.
Since then, Zeon Medical has worked to contribute to society as a unique domestic
manufacturer performing

development, manufacture,and marketing

ofprimarily

cardiovascular and gastrointestinal medical devices.
To not only save lives but also raise people's quality of life amid great changes in theenvironment surrounding medical care, Zeon Medical will continue to develop and improve

President Noboru Yanagidaproducts through its original technologies and with a sense of responsibility and mission
borne by every employee.
We will work uncompromisingly to deliver safe and high-quality products that can be usedwith confidence by doctors and other medical practitioners.

Zeon Medical's research
center and plant

1. Efforts to Reduce Environmental Impact
As a means to reduce our emissions of substances subject to the PRTR Law, we continue making efforts to minimize ourusage volume of ethylene oxide by reducing the operating number of our sterilization machines, of which we currently havefour, to the minimum required by production conditions. Although we have not yet achieved a reduction in our total usage ofethylene oxide, we are maintaining usage volume with respect to production increases.
Regarding the reduction of electricity usage, we continue to engage in steadfast energy-saving initiatives, including
managed temperature settings and the elimination of unneeded lighting. However, with our use of clean rooms enhancing
the impact of weather and with increased electricity usage under increased production also a factor, the effects of ourenergy-saving initiatives were not marked.

-1-FY2015 CSR Website

CSR > Site Reports > Zeon Group (Japan) > Zeon Medical Inc.

2. Environmental Data
Zeon Medical Inc.
Number of substances
Substances
covered byConsumption (tons)
PRTR law
Amount emitted (tons)
Amount generated (before volume reduction)
Industrial(tons)
waste
Amount sent to landfill (tons)
Water resources (Industrial water + Ground water +3Waterworks) consumption (1,000 m )CO2 emissions (tons)
Energy consumption (crude oil equivalent, kL)

FY201012.3
2.3

FY201112.2
2.2

FY201211.6
1.6

FY20131
1.6
1.6

FY2014
1
1.6
1.6

8

22

10

910

7.6

11.2

5.0

4.3

4.5

-

11.7

14.3

17.8

21.9

970
462

969
431

1,143511

1,123
539

1,003
401

One activity undertaken by the Zeon Takaoka Group is ongoing participation in neighborhood clean-up efforts along thenearby Kokubun-hama shoreline and the Himi Coast.
Also, to contribute to the development of the medical device industry in Toyama Prefecture, we are investigating
possibilities for collaboration with local companies through event participation and information exchanges with Toyama
Pharmaceutical Industry Collaborative Research Association, the Hokuriku branch of the Chubu Bureau of Economy,
Trade and Industry, and the Takaoka Municipal Industrial Planning Department.
In R&D, we participated in a research meeting held by the Toyama Industrial Technology Center and are moving forwardwith development in collaboration with local companies.

-2-